首页> 外文期刊>Journal of Cancer Research and Therapeutics >Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level
【24h】

Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level

机译:血浆septin-9和clusterin水平分析对上皮性卵巢癌的早期诊断研究

获取原文
           

摘要

Background and Aim: To investigate the value of peripheral blood plasma levels of septin-9 and clusterin protein in the diagnosis of epithelial ovarian cancer (EOC). Materials and Methods: The peripheral blood plasma samples were obtained from 137 EOC patients, 12 borderline ovarian tumor patients, 10 benign ovarian tumor patients, 41 benign pelvic lesion patients, and 58 healthy women. The peripheral plasma septin-9 and clusterin proteins levels were measured by enzyme-linked immunosorbent assay. The power of test was evaluated with the area under the receiver operating characteristic curve (ROC) (AUC). Results: The mean levels of plasma septin-9 and clusterin in EOC patients were significantly higher than that in healthy women (P = 0.002, P = 0.021). The mean levels of plasma septin-9 in benign pelvic lesion patients were significantly higher than that in healthy women (P = 0.007). The mean levels of plasma septin-9 in epithelial ovarian carcinoma patients with tumor family history or distant metastases were significantly higher than that of patients without (P = 0.040, P = 0.025). The AUC of septin-9 protein was 0.712, when the optimal cut-off point was 0.28, the sensitivity and diagnostic specificity were 82.5% and 50.0%, respectively; the AUC of clusterin was 0.636, and when the optimal cut-off point was 87.96 ng/ml, the sensitivity and diagnostic specificity was 71.5% and 41.4%, respectively. Conclusion: The plasma levels of septin-9 and clusterin in ovarian cancer patients were abnormally elevated, which might be used as potential candidates of peripheral blood tumor biomarkers for early diagnosis of EOC and septin-9 might be related to distal metastases of EOC. The septin-9 might play the promotion role, which protein level relates to not only the distal metastases but also the prognosis of EOC. Due to the limit of sample volume, further enlargement of the sample size and set up of the follow-up system is in need to in-depth study the relationship between plasma protein concentration with the distal metastases, and further explore its correlation with the prognosis of EOC.
机译:背景与目的:探讨外周血血浆septin-9和clusterin蛋白在上皮性卵巢癌(EOC)诊断中的价值。材料与方法:外周血样本来自137例EOC患者,12例交界性卵巢肿瘤患者,10例良性卵巢肿瘤患者,41例良性骨盆病变患者和58名健康女性。通过酶联免疫吸附测定法测定外周血浆septin-9和簇蛋白的水平。用接收器工作特性曲线(ROC)(AUC)下的面积评估测试的功效。结果:EOC患者的血浆septin-9和clusterin的平均水平显着高于健康女性(P = 0.002,P = 0.021)。良性骨盆病变患者血浆septin-9的平均水平显着高于健康女性(P = 0.007)。有肿瘤家族史或远处转移的上皮性卵巢癌患者血浆septin-9的平均水平显着高于无肿瘤家族史的患者(P = 0.040,P = 0.025)。 septin-9蛋白的AUC为0.712,最佳临界点为0.28时,敏感性和诊断特异性分别为82.5%和50.0%。簇蛋白的AUC为0.636,最佳临界点为87.96 ng / ml时,敏感性和诊断特异性分别为71.5%和41.4%。结论:卵巢癌患者血浆septin-9和clusterin水平异常升高,可作为早期诊断EOC的外周血肿瘤生物标志物,septin-9可能与EOC的远端转移有关。 septin-9可能起促进作用,其蛋白水平不仅与远端转移有关,而且与EOC的预后有关。由于样本量的限制,需要进一步扩大样本量和建立随访系统,以深入研究血浆蛋白浓度与远端转移的关系,并进一步探讨其与预后的关系。 EOC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号